The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...
A study has highlighted ways to reduce RSV infections - including a vaccine programme which could reduce antibiotic ...
Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...
Public health officials reiterated the importance of vaccines after seeing a rise in circulating levels of respiratory syncytial virus (RSV).
Vaccine effectiveness was 73 percent against associated ... “These findings provide additional context regarding the benefit of respiratory syncytial virus vaccination among adults aged at least 60 ...